Patents by Inventor Binghe Wang

Binghe Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110144187
    Abstract: Boronic acid-modified DNA-based aptamers can be selected to recognize fibrinogen through binding at a glycosylation site and thus are useful for probing the effect of glycosylation pattern changes on the ability for fibrinogen to mediate blood coagulation. In addition, the aptamers of the disclosure also have anticoagulation effects due to their binding to fibrinogen and its cleavage product fibrin. The present disclosure, therefore, encompasses methods for inhibiting fibrin coagulation with an aptamer capable of specifically binding to a glycosylation site of fibrinogen or fibrin. The disclosure further provides oligonucleotide aptamers comprising at least one nucleotide having a boronic acid thereon, where the aptamer is capable of selectively binding to a glycosylation site of fibrinogen, or the derivative thereof.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 16, 2011
    Inventors: Binghe Wang, Minyong Li, Nanting Ni, Yidan Liu
  • Patent number: 7767817
    Abstract: Described herein are boronic acid fluorescent compounds and methods of use thereof.
    Type: Grant
    Filed: September 7, 2004
    Date of Patent: August 3, 2010
    Inventors: Binghe Wang, Xingming Gao, Wenqian Yang, Hao Fang, Jun Yan
  • Publication number: 20100137249
    Abstract: The present disclosure encompasses compounds and compositions that are useful as specific AI-2 antagonists for the control of bacterial quorum sensing. Although the AI-2 antagonists according to the present disclosure may not have bactericidal effect, their ability to attenuate virulence, drug resistance, and/or biofilm formation have therapeutic benefits. In addition, the AI-2 antagonists of the present disclosure can also be used as tools to probe bacterial AI-2 functions. The present disclosure also encompasses methods for inhibiting or attenuating microbial virulence, biofilm formation, and drug resistance. The methods are suitable for preventing bacteria from accruing and forming extensive biofilms that may be a health or hygiene hazard or a physical issue, such as in the blockage of water or fuel lines.
    Type: Application
    Filed: June 6, 2008
    Publication date: June 3, 2010
    Inventors: Binghe Wang, Nanting Ni, Junfeng Wang, Chung-Dar Lu, Han-Ting Chou, Minyong Li, Shilong Zheng, Yunfeng Cheng, Hanjing Peng
  • Publication number: 20070274922
    Abstract: Described herein are boronic acid fluorescent compounds and methods of use thereof.
    Type: Application
    Filed: September 7, 2004
    Publication date: November 29, 2007
    Inventors: Binghe Wang, Xingming Gao, Wenqian Yang, Hao Fang, Yun Yan
  • Patent number: 6916660
    Abstract: Fluorescent sensor compounds having the formula: wherein L is selected from the group consisting of alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, and arylalkyloxyl; each m, m?, n, n?, p, and p? is independently an integer from 0 to 4, inclusive; and each R1, R?1, R2, R?2, R3 and R?3 is independently selected from the group consisting of hydrogen, alkyl, alkylene, aryl, cycloalkyl, alkoxy, aryloxy, arylalkyl, arylalkyloxyl, halo, substituted and unsubstituted amino, and substituted and unsubstituted thiol, are useful for the selective detection of saccharides such as glucose and sialyl Lewis X. The compounds find particular use in detecting saccharides in biological samples, and in detecting cancer cells that express cell surface polysaccharides such as sialyl Lewis X.
    Type: Grant
    Filed: May 13, 2003
    Date of Patent: July 12, 2005
    Assignee: North Carolina State University
    Inventors: Binghe Wang, Brent Weston, Wenqian Yang
  • Publication number: 20040048390
    Abstract: Fluorescent sensor compounds having the formula: 1
    Type: Application
    Filed: May 13, 2003
    Publication date: March 11, 2004
    Applicants: North Carolina State University, University of North Carolina
    Inventors: Binghe Wang, Brent Weston, Wenqian Yang
  • Patent number: 5672584
    Abstract: Provided are cyclic prodrugs of biologically active peptides and peptide nucleic acids exhibiting improved cell membrane permeability and enzymatic stability, containing 3-(2'-hydroxy-4',6'-dimethyl phenyl)-3,3-dimethyl propionic acid and its deriveatives and acyloxyalkoxy linkers. Also provided are pharmaceutical compositions containing effective amounts of these cyclic prodrugs in combination with pharmaceutically acceptable carriers, excipients, or diluents.
    Type: Grant
    Filed: April 25, 1995
    Date of Patent: September 30, 1997
    Assignee: The University of Kansas
    Inventors: Ronald T. Borchardt, Teruna Siahaan, Sanjeev Gangwar, Valentino J. Stella, Binghe Wang